VTU-49803-20890
3 vaccinations
1 coded response
35 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 236 / VA
- Registered
- 2021-02-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-03
Registered in v-safe
-
2021-02-03
Dose 1 — Moderna
- 2021-02-03
-
2021-02-04
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-05
-
2021-02-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-10
- 2021-02-17
- 2021-02-24
-
2021-03-03
Dose 2 — Moderna
-
2021-03-03
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-10
- 2021-03-17
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-14
- 2021-06-02
- 2021-09-01
-
2021-12-22
Dose 3 — Moderna
-
2021-12-26
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Redness, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-12-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Redness · Headache, Fatigue or tirednessAdult check-in
- 2021-12-29
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-01-28
- 2022-02-02
- 2022-03-23
- 2022-06-22
-
2022-12-22
Survey response — 12 months, dose 3MedDRA: Bronchitis, COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Bronchitis and COVIDMedDRA releases: 2024-11 · check-in free text available
-
2022-12-22
Report sent to call center — 12 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-12-23
Call successfulNot applicable - Accidental Reporting
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-03 | Moderna | |
| 2 | 2021-03-03 | Moderna | |
| 3 | 2021-12-22 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-12-22 | Successful 2022-12-23 |
Not applicable - Accidental Reporting |
Free text
Release 12 — 12 months, dose 3
Symptoms: Bronchitis and COVID
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Bronchitis | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release